About us
The Vaccine Impact Modelling Consortium (VIMC) is an international community of modellers providing high-quality estimates of the public health impact of vaccination, to inform and improve decision making.
​
By 2027, our core aims are:
​
-
to provide reliable and accessible estimates of vaccine impact across the Gavi portfolio
-
to address critical modelling-related vaccine policy questions raised by stakeholders who are dynamically engaged in our work
-
to translate our modelling to real-world policy that improves health outcomes
-
to foster a diverse international community of vaccine impact modellers, inclusive of modellers in low- and middle-income countries
-
to provide training in infectious disease modelling and its application to vaccine-preventable diseases for both modellers and policymakers.
Specific aims of our research programme on climate change are:
-
to better characterise the mechanistic relationship between environment, climate and disease transmission
-
to assess implications of long-term climate change for disease burden, range and routine vaccination
-
to optimise control programmes to respond to seasonal variation in disease burden and the consequences of increasingly frequent extreme climate events.
VIMC is now in its second phase – VIMC 2.0 – from 2022 – 2027, focused on the goals above. VIMC’s first phase – VIMC 1.0 – ran from 2016 – 2022. This phase focused on delivering a more sustainable, efficient, and transparent approach to generating estimates of disease burden and vaccine impact, for Gavi investments.
​